Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Researchers have found that gut microbes can help frogs to cope with hot temperatures. The findings could pave the way to for new conservation approaches for animals threatened by climate…
The impact of age-induced microbiota alterations facilitates the accumulation of CML metabolite in the microglia of mice and humans.
Researchers have found that a specific microbial metabolite may boost the efficacy of anticancer therapy in people with TNBC. The findings could inform the development of improved treatments for TNBC.
New research investigates the role of lung microbiota in pediatric patients with lung infection or injury after bone marrow transplantation.
Researchers uncover the gut microbiota changes that happen in the very early stages of heart disease. The microbial and metabolic profiles identified could be used as markers of the transition…
A recent study investigates the role of the gut microbiota in helping the gallbladder regulate the innate immune response
The findings could help to develop microbiota-based strategies to advance immunothery treatments for melanoma.
New research reveals that ocean-derived genes are common in the human microbiota, highlighting the interplay between diet and adaptation of human gut microbes.
Researchers have found that β-carotene modifies the abundance of certain gut microbes and improves the intestinal dysfunctions
Researchers have found that combining a probiotic product with immunotherapy may boost anti-tumor responses in people with advanced kidney cancer.
